Wenbing Sheng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Pluripotent Stem Cells

Breast Cancer Cells

Gas Chromatography

Top Venues

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hui Zhong, Qi Jiang, Cong Wu, Huanghe Yu, Bin Li, Xu-Dong Zhou, Ronggeng Fu, Wei Wang, Wenbing Sheng
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands. Molecules (Basel, Switzerland) 29 (2) (2024)
Hui Zhong, Qi Jiang, Cong Wu, Huanghe Yu, Bin Li, Xu-Dong Zhou, Ronggeng Fu, Wei Wang, Wenbing Sheng
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands. Molecules (Basel, Switzerland) 29 (2) (2024)
Cong Wu, Qi Jiang, Hui Zhong, Xudong Zhou, Leping Liu, Tong Pan, Chao Liu, Wei Wang, Wenbing Sheng
Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Hui Zhong, Qi Jiang, Cong Wu, Huanghe Yu, Bin Li, Xu-Dong Zhou, Ronggeng Fu, Wei Wang, Wenbing Sheng
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands. Molecules (Basel, Switzerland) 29 (2) (2024)
Hui Zhong, Qi Jiang, Cong Wu, Huanghe Yu, Bin Li, Xu-Dong Zhou, Ronggeng Fu, Wei Wang, Wenbing Sheng
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands. Molecules (Basel, Switzerland) 29 (2) (2024)